Ronan Abgral

Does ¹⁸F-FDG PET/CT Improve the Detection of Posttreatment Recurrence of Head and Neck Squamous Cell Carcinoma in Patients Negative for Disease on Clinical Follow-up?

Ronan Abgral, S. Querellou, G. Potard et al. · Journal of Nuclear Medicine · 2008 · 241 citations · Full text

Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis

Marc R. Dweck, Ronan Abgral, Maria Giovanna Trivieri et al. · JACC. Cardiovascular imaging · 2017 · 190 citations · Full text

Positron Emission Tomography, Health Sciences, Medical Imaging +6

Pretreatment ¹⁸F-FDG PET/CT Radiomics Predict Local Recurrence in Patients Treated with Stereotactic Body Radiotherapy for Early-Stage Non–Small Cell Lung Cancer: A Multicentric Study

Gurvan Dissaux, Dimitris Visvikis, Ronrick Da‐ano et al. · Journal of Nuclear Medicine · 2019 · 161 citations · Full text

Good clinical practice recommendations for the use of PET/CT in oncology

Pierre‐Yves Salaün, Ronan Abgral, O. Malard et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 135 citations · Full text

Positron Emission Tomography, Oncologic Imaging, Medical Imaging +6

Performance of 18Fluorodeoxyglucose-Positron Emission Tomography and Somatostatin Receptor Scintigraphy for High Ki67 (≥10%) Well-Differentiated Endocrine Carcinoma Staging

Ronan Abgral, Sophie Leboulleux, Désirèe Deandreis et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 107 citations · Full text